Biomea Fusion Stock Falls on Termination of Proposed Public Offering

By Kelly CloonanShares of Biomea Fusion slid after the company terminated its proposed public offering of securities.The stock declined 16% to $1.44 on Wednesday. Shares are up 16% year to date.The clinical-stage diabetes and obesity company said it determined that current market conditions aren't…